Kevin Rudolph
About
Kevin Rudolph is from Raleigh-Durham-Chapel Hill Area. Kevin is currently Director, Business Development N. America & APAC at Averix Bio, located in Wilson, North Carolina, United States.
Come check out Kevin Rudolph's email address on finalscout.com, a free professional database with 500 million business professionals and 200 million companies.
Kevin Rudolph's current jobs
Averix Bio offers Active Pharmaceutical Ingredient (API) Phytocannabinoids to global the pharmaceutical, nutraceutical, veterinary, cosmetic, food, and beverage sectors from a cGMP (21 CFR Part 210 and Part 211) and ICH Q7 compliant extraction facility. Cannabinoid ingredients: ● API CBD Isolate, DMF with the US FDA #36798 ● CBG Isolate ● Broad Spectrum Crystal Resistant Distillate ● Water Dispersible CBD Powder ● Custom Formulations Averix Bio is the first botanical-based cannabinoid research and extraction company in the United States that meets cGMP 21 CFR Part 210 and Part 211 and ICH Q7 compliance. We offer Active Pharmaceutical Ingredient (API) botanical-based CBD Isolate for pre-clinical, clinical, and consumer goods and a Drug Master File (DMF) with the US FDA. The company offers the highest-quality cannabinoid ingredients for use in the pharmaceutical, nutraceutical, veterinary, cosmetic, food, and beverage sectors. Our team has more than 60 years of combined cGMP/pharmaceutical experience, and we work with specialty consultants with a broad range of compliance expertise. Averix Bio is on a mission to bring healthier cannabinoid-based medical solutions to patients around the world.